In addition, we also demonstrated that high amounts of methylated HBP1 and low GSN expression levels positively correlate with poor prognosis of cervical cancer patients, indicating that methylated HBP1-GSN axis is critical for tumorigenesis, and targeting this axis may provide a new therapeutic strategy for treating cancers. Here, HBP1 is linked to cervical carcinoma.